Multidimensional phenotyping of breast cancer cell lines to guide preclinical research
Jodi M. Saunus(Translational Research Institute), Sunil R. Lakhani(Sullivan Nicolaides Pathology), Andrew J. Dalley(The University of Queensland), Jamie R. Kutasovic(The University of Queensland), Peter T. Simpson(The University of Queensland), Fares Al‐Ejeh(QIMR Berghofer Medical Research Institute), Georgia Chenevix‐Trench(QIMR Berghofer Medical Research Institute), Kum Kum Khanna(Queensland University of Technology), Julie K. Johnson(University of North Carolina at Chapel Hill), Eva Lorsy(The University of Queensland), Debina Sarkar(University of Auckland), Esdy Rozali(QIMR Berghofer Medical Research Institute), Marjan Askarian-Amiri(University of Auckland), Leesa Wockner(Johannes Gutenberg University Mainz), Sibylle Cocciardi(QIMR Berghofer Medical Research Institute), Chanel E. Smart(Vita-Salute San Raffaele University), Lynne Reid(The University of Queensland), Priyakshi Kalita‐de Croft(The University of Queensland), Rebecca L. Johnston(QIMR Berghofer Medical Research Institute), Amy E. McCart Reed(The University of Queensland), Tatjana Seidens(QIMR Berghofer Medical Research Institute), Mariska Miranda(The University of Queensland), Ana Cristina Vargas(Douglass Hanly Moir Pathology)
Cited by 34
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Association analysis identifies 65 new breast cancer risk loci
|Nature|2017|1.6k
The 2019 World Health Organization classification of tumours of the breast
|Histopathology|2020|1.1k